Other Corporate Information

GOTHENBURG, Sweden, October 28, 2025 – Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL) hereby invites investors and shareholders to an […]

GOTHENBURG, Sweden, October 16, 2025 – Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL) announces today that the company will participate

GOTHENBURG, Sweden, September 30, 2025 – Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), announces today that the company has successfully

GOTHENBURG, Sweden, September 26, 2025 – Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), announces today that the transfer of the

GOTHENBURG, Sweden, August 21, 2025 – Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), hereby invites investors, analysts and media to

GOTHENBURG, Sweden, July 16, 2025 – Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), announces today that the company has successfully

GOTHENBURG, Sweden, June 12, 2025 – Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), announces today that the company has completed

GOTHENBURG, Sweden, June 3, 2025 – Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), announces today that the company is participating

GOTHENBURG, Sweden, June 2, 2025 – Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), announces today that the company has been

GOTHENBURG, Sweden, May 14, 2025 – Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), announces today that the company’s CEO Petter